The high wave will become a large player in the German medical center with the acquisition of shares in the Remexian Pharma GMBH
In the last 12 months, Remexian has income 65 million euros income
Remexian sold 7 tons of cannabis flower in the quarter of 2025, which is 43 tons of 16% imported to Germany in the quarter
Calgary, ABD, August 14, 2025 / PRNEWSWIRE / – High Tide Inc. (“High Termosity” or “Company”) (NASDAQ. HITI) (FSE: PHARMA GMBH (“Remexian”), 27.2 million euros (“transaction”) and will have an option to obtain the rest of interest in Remexia.
It was founded in 2018. Among the buyers of all Germany’s doctors, Remexian has one of the most popular in the world, which is currently licensed from 19 countries, including Canada, who represents about 33% of their total imports to Germany. Taking into account more than $ 1.9 billion from Canadian Canadian sales, a high channel has a Canadian shopping expertise and relationships to make this transaction significantly increase the Canadian Canadian department in Germany.
“Remexian is ideal for us, not only prices, but also with its operational approach, which prevents the highest price team. Said Raj Grover, the founder and CEO of the High Channel.
“With this high-quality acquisition, it’s about $ 100 million to significant EBITDA, we will talk about more affordable prices, which are imported to the highest quality brands,” Mr. Gurverer added.
“We are truly energy with a strong certigion that we have found with a high wave, the impressive scale of which enhances our influence in Germany,” said Remexyan co-founder Marcus Wenner. “Our two companies have deliberately have a strategic approach to becoming leaders in our relevant markets.
In April 2024, the demand for medical cannabis continued to accelerate in the country since the adoption of the German consumer Act of Germany. Over the past year, the number of medical cannabis has sharply increased by 250,000 to about 900,000 to 1 billion euros (BFAMM). 2025 (37.5 tons) and twelve months roll in total 134 tons, maintaining its place as the world’s largest medical importer. The growth of demand has also stimulated the position of Canada as a leading global exporter, the country’s German imports, about 36 tons in the first six months of 2025.
The Remexian, led by Francesco Baghan and Stefan Adome, is a leader in German Medical Cannabis, with an annual income, and 43 tons of 16 million euros and 15 million euros and a quarterly imported in Germany.
When the acquisition concluded, the company considered the potential of changes in Germany’s medical cannabis. The company believes that even if the restrictions are posted on telemedicine and postpone, which is subject to a long-term legislative review, the market will continue to grow after the adjustment period.
___________________________
Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.
Oursource. War of flowers’ prices. German boom, the reality of Great Britain
³SOURCE: BFARM (Q2 2025 Update)
Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.
Deal details
The transaction is subject to the wing length of time, among other things, it is necessary to exchange TSX enterprise (“TSXV”) and other customs conditions and are expected to be closed in the coming weeks. This implies a 53.4 million euros app that represents the 3,64065 times an annual Ebitda, which was created in six months of March 31, 2025, and is subject to certain adjustments based on working capital and closure. For 51% of the acquired equality, the preliminary estimated price of 27.2 million euros will be satisfied as follows:
42% of high-tidal tidal shares (“Ri-High Shares”) Price in US $ 2.1912, presenting the average average price for NASDAQ for NASDAQ.
29% cash.
29% of loans from sellers (“Credit”). The loan will ripen on December 31, 2029, annual annual interests (paid quarterly) will lead to a pre-payment company without penalty.
In addition to the above, the Remexian owners agreed to provide a high-channel option that acquires the remaining interests remaining in the Remexian through high tidal tide (“Call version”). The call option will be implemented at any time for a five (5) years of closing twenty four (24) monthly anniversary (“term” of the call version). The call option is carried out for the value of the enterprise, which is equal to the 12th Tebit Date of the Adjusted EBITDA, if the call version is performed in the first twelve (12) month of the call version. In addition, the high channel agreed to provide Remember owners to reset the remaining interests in high tidal lecture. Taking into account the option or set version, given the case, it will be satisfied with the Cash and High Combination Character at the discretion of the high wave. The call option has a minimum price of 15 million euros, and is subject to at least 40% of the payment of minimum cash, and the installed version is subject to at least 30% cash.
Any high levels related to the transaction are subject to four months and one day of stateration.
About a high wave
High Tide, Inc. is a leading community, retail Cannabis, developed to unleash the full cost of the world’s most powerful factory. The whole subsidiary of it, Canna Kabana, is the second largest brand of Cannabis in the world. High wave (HITI) is unique around cannabis consumer, fully diversified and fully integrated with all components of cannabis, including:
Bricks & Mortar Retail. Canna CABANA is Canada’s largest retail network in Canada, 203 Current places that pass through British Columbia, Alberta, Saskakateva, Manitoba, Ontario. In 2021, Kanina Cabana became the retail sale of the Cannabis Discount Club in the world.
Retail innovation. Fastendr ում is a unique and fully automated technology that uses retail kiosks to facilitate better purchase experience with observation, order and pickup.
Consumption accessories. The high wave operates the world’s leading e-commerce platforms, including grasscity.com, Smokecartel.com, DailyHighclub.com and Dankstop.com.
Brands. The list of HIGH Wave Industry and Consumer Brand includes Bud ™, Daily High Club Wea, Daily High Club ™, Vodka Glass Pass ™, Donezilla ™, Atomik ™ etc.
CBD. High channel continues to develop consumer CBD capabilities via Nuleafnaturals.com, fabcbd.de and brabscbd.co.uk.
Wholesale distribution. The high wave keeps the category of cannabis through wholesale solutions through Valiant.
Licensing. The high channel continues to push the culture of Cannabis through fresh partnership and license agreements under the name of the famous brandz.
The high tide is consistently moving forward before the fourth year in a row was named one of the best growing companies in Canada in 2024, as well as for the fastest growing companies in 1023. Tide, visit www.hightideinc.com. Do not miss high pages of high tidal tide in Sedan and Edgar for investment.
NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number
Statistics Canada released August retail sales for the country, with Cannabis sales are on the rise up 1.4% from July levels to C$498.7 million. This sequential increase also increased on a daily basis due to the same number of days compared to the previous month. July, originally reported at C$485.0 million, was revised slightly higher to C$491.8 million. August sales were up 0.9% from a year earlier, up from 8.3% in May and 7.5% in June. This was also below the 20.3% growth rate in August 2023 and above the previous lowest annual growth since the start of legalization in September 2024 of -0.9%, and it was significantly down from the 9.1% growth in December. In 2024, total sales grew 4.5% to C$5.39 billion, and in 2025 they are up 4.5% year-to-date.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales rose 4.8% from July and fell 2% from a year ago. Alberta was down 0.1% from July and up 4% from a year ago. British Columbia was up 8.7% from July after a 9% year-over-year increase, while Quebec was down 10.2% from July and 5% from a year ago.
September sales data will be released on November 21.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
This data-driven, fact-based search engine will be continually updated based on new financial filings so readers can stay up-to-date. Companies must file with the SEC or SEDAR and be current to be considered for inclusion. When we launched this resource in May 2019, companies with more than $2.5 million in quarterly revenue qualified. As the industry has grown and as more companies have gone public, we have raised the minimum several times, including $5 million in October 2019, $7.5 million in June 2020, up to $10 million in November 2020, $12.5 million in August 2021, $12.5 million in August 2021, and $202 in September 2021. million dollars. hemp industry, we raised the minimum again in May 2024. The senior roster has a minimum of US$50 million (C$70.2 million) and the junior roster now has a minimum of US$25 million (C$35.1 million).
Note on adjusted operating income
In May 2019, we added an additional measure, Adjusted Operating Income, which we detailed in our newsletter. The calculation takes reported operating income and adjusts it for any changes in the fair value of biological assets required under IFRS accounting. We believe this adjustment improves comparability between companies under IFRS and GAAP accounting. We note that operating income can often include one-time items such as stock compensation, inventory write-offs or public listing costs, and we encourage readers to understand how these non-cash items may impact quarterly financials. Many companies have moved from IFRS to US GAAP accounting, which has reduced our need to make adjustments. Please note that our rating only includes actual reported income and non pro forma income. We also note that companies with non-hemp operations must provide segment-level financial statements detailing not only revenue but also operating profit in order for their operating profit to be included in the tracking. Currently, Aurora Cannabis (NASDAQ: ACB ) (TSX: ACB ), Jazz Pharma (NASDAQ: JAZZ ) and Tilray (TSX: TLRY ) (NASDAQ: TLRY ) do not provide this information.
Tracker inclusion updates
At the time of our last update on August 13, 16 companies were eligible for inclusion on the senior lists, including 13 in USD and 3 in Canadian currency, and 11 companies on the junior list. Now, 14 companies denominated in US dollars and 5 denominated in Canadian dollars qualify for the senior lists, for a total of 19 now. The junior list includes 11 companies that report in US dollars and 1 in Canadian dollars. Tracking public cannabis company revenue and earnings on a combined basis now includes 31 companies. One company, Glass House Brands (OTC: GLASF) (NEO: GLAS.AU) moved from the American Junior list to the Senior list. Fluent (OTC: CNTMF) (CSE: FNT.U) has been added to the American Junior list. In Canada, Auxly Cannabis (OTC: CWBTF) (TSX: XLY) has joined the Junior List.
Companies that have reported since mid-August are included
There have been few reports since our last update, as most of these companies are operating at the end of December and meet earlier deadlines than the middle of the month.
Senior and Junior – US Dollar Report
Neither company has yet reported Q3, but updates will begin to trickle in next week. Tilray brands (NASDAQ: TLRY ) (TSX: TLRY ) reported its fiscal quarter earlier this month. The diversified company grew its cannabis business 5% year-over-year as it declined 5% sequentially. Overall for the company was up from a year ago, but adjusted EBITDA was lower than expected due to lower gross margin.
One major company that has diversified beyond cannabis, and Scotts Miracle-Gro (NYSE: SMG ), will report its fiscal 4th quarter by the end of the year. It has not yet scheduled the next conference call, although its website suggests 11/5 could be a tentative date.
Some of the 5 largest MSOs have scheduled calls for their Q3 financial reports, although GTI has changed its policy and will not be hosting any for now. Here is the current outlook of all of them.
Curaleaf (OTC: CURLF ) (TSX: CURA ) – revenue is expected to decline 4% year-over-year to $317.1 million, with adjusted EBITDA of $66.4 million, a 12% decline.
Trulieve (OTC: TCNNF ) (CSE: TRUL ) – Revenue is expected to increase 1% year-over-year to $296 million, and adjusted EBITDA is expected to decline less than 1% to $95.9 million, a 13% decline sequentially.
Green Thumb Industries (OTC: GTBIF ) (CSE: GTII ) – revenue is expected to increase 1% year-over-year to $290.9 million and adjusted EBITDA is expected to decline 9% to $81.9 million.
Verano Holdings (OTC: VRNOF ) (NEO: VRNO ) – revenue is expected to decline 6% to $208 million and adjusted EBITDA is expected to decline 6% to $60.7 million.
Cresco Labs (OTC: CRLBF ) (CSE: CL ) – Revenue is expected to decline 9% to $163.7 million and adjusted EBITDA is expected to decline 29% to $36.5 million.
Senior and Junior – Canadian Dollar Report
Since our last update, only High Tide (NASDAQ: HITI ) (TSXV: HITI ) has reported among Canadian listed companies. Revenue was up sequentially in its fiscal quarter, and operating profit was just under $4 million.
One of Canada’s senior list members, SNDL, has scheduled its quarterly call.
The Public Cannabis Company Earnings Tracker by New Cannabis Ventures is not a recommendation of any company, and you should not use it as investment advice. A tilde next to a date means an approximate date. All calculations are derived from SEC or SEDAR filings. Any questions or licensing inquiries please contact us.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
TILRAY brands report a strong first quarter of financial results, emphasizing continuous growth with a record Q1 $ 210 million and net income
Operating efficiency and focus on the profitability of $ 1.5 million net income, adjusted EBITDA increased from 9% to $ 10 million, and $ 34 million annually improved.
Canadian adult Canadian Cannabis gross revenues increased by 12%, maintaining a position # 1 in the expansion of income and market share. International women’s income increased by 10%
Balance reinforced to $ 265 million in cash; Net debt has been reduced to $ 4 million
Repeats EBITDA Outlook adjusted for $ 2026 – $ 72 million
New York and London and London, Ontario, October 09, 2025 (Globe Newswire) – TILRAY Brands, Inc. (“Tilray”, “Our”, “We” or “Company”) (NASDAQ. TLRY; TSX.
His Evin D. Simon, President and Chief Executive Officer, as we enter 2026 financial, the results of the first quarter of “Tilra” outlines our shareholders of our strategic vision and disciplinary balance. Our global platform positions TILRAY brands will not only participate, but also to guide, global hemp, beverages and health effects. “
Mr. Simon continued. It is available to expand access, innovation and supports the world’s responsible regulatory progress. These achievements and nominated tendencies strengthen my unbreakable belief in the trajectory of the trail of Tilra and our ability to give our investors long-term value.
Financial needs: All comparisons made in the previous year
Net incomes increased by 5% in the first quarter to $ 209.5 million compared to 200.0 million.
Gross profit in the first quarter amounted to $ 57.5 million compared to $ 59.7 million.
Gross margin in the first quarter was 27% compared to 30%.
Cannabis Net revenues increased by 5% in the first quarter to $ 64.5 million, which is $ 61.2 million.
The gross gain of greens in the first quarter amounted to $ 23.3 million compared to $ 24.2 million.
The gross Cannabis margin in the first quarter was 36% compared to 40%.
The net income of the beverages in the first quarter amounted to $ 55.7 million compared to $ 56.0 million.
The gross profit in the first quarter amounted to $ 21.3 million compared to $ 22.9 million.
The gross margin in the first quarter was 38% compared to 41%.
Net health revenues increased to $ 15.2 million in the first quarter, compared to $ 14.8 million.
The gross health margin in the first quarter was 32% and unchanged.
The distribution net income in the first quarter amounted to $ 74.0 million compared to $ 68.1 million.
The distribution of gross margin in the first quarter was 11% compared to 12%.
Net income was $ 1.5 million in the first quarter, compared to the net loss of the dollar (34.7) million.
The regulated net income increased by $ 10.0 million in the first quarter to $ 3.9 million compared to $ (6.1) million.
Settled EBITDA increased by 9% in the first quarter to $ 10.2 million compared to $ 9.3 million.
Cash flow. The cash used in the operation has significantly improved by $ 34.0 million (1.3) million (35.3) million.
Balance update. In the first quarter, TILRAY reduced its outstanding debt for $ 7.7 million, further strengthening the balance. As a result, the net debt ratio related to the twelve months adjusted EBITDA was reduced to 0.07X. Our $ 264.8 million in cash is providing great tiltric flexibility for strategic opportunities.
Live audio web web
These results in the morning 8: 30 o’clock at 8 o’clock. On 30, web brands will be conducted to discuss these results. Investors can connect to the Department of Measures and Presentations of LIVEST Investors. Reproduction will be presented on the company’s website.
About TILRAY brands
TILRAY Brands, Inc. (Nasdaq: TLRY; TSX; TSX
For more information on how we raise life through communication moments, visit Tilray.com and follow all the social platforms of @ TILRAY.
NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number
